Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KCTD3 deficiency disrupts axon initial segment organization and neurite outgrowth in a neurodevelopmental disorder mouse model.

Communications biology·2026
Same author

Expanding the clinical spectrum of RNU4ATAC-opathies: more frequent and diverse than assumed.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Pathological disruption of CELF2 shuttling causes neuronal hyperactivity, learning deficits, and seizures.

The Journal of clinical investigation·2026
Same author

Burst-Suppression EEG in Early Infantile Developmental and Epileptic Encephalopathies: Phenotype, Genotype, and Outcome.

Neurology·2026
Same author

Trametinib for multiple non-ossifying fibromas due to KRAS mosaic mutations: two case reports.

Communications medicine·2026
Same author

Author Correction: Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.

Nature genetics·2026

Related Experiment Video

Updated: May 18, 2026

Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing
08:39

Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing

Published on: September 1, 2017

Refining the phenotype associated with MEF2C point mutations.

Thierry Bienvenu1, Bertrand Diebold, Jamel Chelly

  • 1CNRS UMR 8104, Institut Cochin, Laboratoire de Génétique des Maladies Neurodéveloppementales, Université Paris Descartes, Paris, France. thierry.bienvenu@inserm.fr

Neurogenetics
|September 25, 2012
PubMed
Summary
This summary is machine-generated.

Researchers identified a new MEF2C gene mutation in a patient with severe intellectual disability and epilepsy. This finding helps refine criteria for screening patients with severe intellectual disability for MEF2C gene deficiency.

More Related Videos

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

Related Experiment Videos

Last Updated: May 18, 2026

Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing
08:39

Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing

Published on: September 1, 2017

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

Area of Science:

  • Genetics
  • Neuroscience
  • Developmental Biology

Background:

  • Mutations in the MEF2C gene are linked to severe intellectual disability, absent speech, motor deficits, and epilepsy.
  • MEF2C plays a crucial role in brain development, including neurogenesis, neuronal migration, and differentiation.

Purpose of the Study:

  • To establish criteria for selecting patients with severe intellectual disability for MEF2C gene screening.
  • To characterize the phenotype associated with novel MEF2C mutations.

Main Methods:

  • Clinical data from a new patient with a frameshift MEF2C mutation (c.457delA) were analyzed.
  • Phenotypic data from previously reported patients with MEF2C point mutations were combined with the new case.
  • A targeted search strategy for MEF2C mutations was developed based on combined clinical data.

Main Results:

  • A novel MEF2C frameshift mutation (c.457delA) was identified in a patient presenting with severe intellectual disability, epilepsy, and hand stereotypies.
  • The study identified a specific phenotype associated with MEF2C deficiency, including severe intellectual deficiency, absence of language, hypotonia, strabismus, and early-onset epilepsy.
  • Epilepsy in these patients often begins after six months of age and is frequently well-controlled with valproate.

Conclusions:

  • The study refines the clinical criteria for suspecting MEF2C gene mutations in patients with severe intellectual disability.
  • Identifying specific clinical features aids in the targeted screening for MEF2C deficiency, improving diagnostic yield.
  • This work expands the understanding of MEF2C-related neurodevelopmental disorders and associated phenotypes.